Prof. Dr. Hürremgül ÖNGEN

Yayın Ağı

Makaleler 30

1. Cytogenetic and FISH Examination of 3p Abnormalities in Lung Cancer Patients

Bakhshaliyeva N., ÇIRAKOĞLU A., Ongen H. G., Bil Tuncay E., ARGÜDEN Y.

Experimed , cilt.14, sa.1, ss.26-39, 2024 (Scopus)

2. Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study

Öngen H. G., AKDENİZ B., Düzenli M. A., Chernyavsky A., Dabar G., Idrees M., et al.

Drugs - Real World Outcomes , cilt.11, sa.1, ss.149-165, 2024 (ESCI)

3. Chronic thromboembolic pulmonary hypertension in patients with persistent chest symptoms after acute pulmonary embolism

Sahutoglu E., Tuncay E., Aras G., Yenturk E., Kanmaz D., Ongen H. G., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.25, sa.1, ss.24-29, 2021 (SCI-Expanded)

4. Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease

Cimci M., BÖREKÇİ Ş., KILIÇKIRAN AVCI B., Hysi E., Ongen H. G., KARADAĞ B., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.48, sa.3, ss.263-269, 2020 (ESCI) Sürdürülebilir Kalkınma

5. Comparison of Different Pulmonary Hypertension Screening Algorithms in Patients with Systemic Sclerosis

Erdogan M., Avci B. K., Ersoy Y., Ebren C., Ongen Z., Ongen G., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded)

6. What should be the appropriate minimal duration for patient examination and evaluation in pulmonary outpatient clinics?

Musellim B., Borekci S., Uzan G., Sak Z. H. A., Ozdemir S. K., Altinisik G., et al.

ANNALS OF THORACIC MEDICINE , cilt.12, sa.3, ss.177-182, 2017 (SCI-Expanded)

7. RELATIONSHIP BETWEEN ABNORMALITIES ON HIGH-RESOLUTION COMPUTERIZED TOMOGRAPHY, PULMONARY FUNCTION, AND BRONCHOALVEOLAR LAVAGE IN PROGRESSIVE SYSTEMIC SCLEROSIS

Cakmak G., Can T. S., Gungogdu S., Akman C., Ikitimur H., Musellim B., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.33, sa.4, ss.349-354, 2016 (SCI-Expanded)

8. HOW CORRECT ARE THE ASSUMPTIONS MADE DURING THE DEVELOPMENT OF TUBERCULOSIS SCREENING ALGORYTHMS BEFORE TNF-ALPHA ANTAGONISTS?

Hacioglu A., Ozguler Y., Borekci S., Hamuryudan V., Kecebas H., Tascilar E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.702, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

9. MALIGNANCIES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TNF-ALPHA ANTAGONISTS

Ozguler Y., Esatoglu S. N., Keskin D., Hatemi G., Hamuryudan V., Pala A. S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1040, 2015 (SCI-Expanded)

10. How Correct Are the Assumptions Made for Tuberculosis Screening Algorythms before TNF-Alpha Antagonists?

Hacioglu A., Ozguler Y., Borekci S., Hamuryudan V., Kecebas H. D., Tascilar E. K., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

11. The relationship between smoking habit and tuberculosis in patients under anti-TNF-alpha treatment

Borekci S., Duman B., Mazican N., Atahan E., Musellim B., Ongen G., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.42, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

12. A Retrospective Case-Control Study, Factors Affecting Treatment Outcomes for Pulmonary Tuberculosis in Istanbul, Turkey

BABALIK A., Kilicaslan Z., KIZILTAS S., GENCER S., Ongen G.

BALKAN MEDICAL JOURNAL , cilt.30, sa.2, ss.204-210, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

13. THE COST-OF-DISEASE OF DEEP VENOUS THROMBOSIS AND ITS SHORT- AND LONG-TERM CLINICAL CONSEQUENCES IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS

Deger C., Ozdemir O., Bozkurt K., Demir M., Ince B., Kultursay H., et al.

VALUE IN HEALTH , cilt.16, sa.3, 2013 (SCI-Expanded)

14. THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY

Marmarali B., Ozdemir O., Bozkurt K., Demir M., Ince B., Kultursay H., et al.

VALUE IN HEALTH , cilt.16, sa.3, 2013 (SCI-Expanded)

15. THE COST-OF-DISEASE OF THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION AND ITS TREATMENT IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS

Deger C., Ozdemir O., Bozkurt K., Demir M., Ince B., Kultursay H., et al.

VALUE IN HEALTH , cilt.16, sa.3, 2013 (SCI-Expanded)

16. THE COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO ENOXAPARIN PLUS ADJUSTED-DOSE WARFARIN FOR THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT) IN TURKEY

Parali E., Ozdemir O., Bozkurt K., Demir M., Ince B., Kultursay H., et al.

VALUE IN HEALTH , cilt.16, sa.3, 2013 (SCI-Expanded)

17. Pulmonary tuberculosis incidence in Turkish prisons: importance of screening and case finding strategies.

Öngen G., BOREKCI S., İÇMELI Ö., BIRGEN N., KARAGÜL G., AKGÜN S., et al.

Tuberkuloz ve toraks , cilt.61, ss.21-7, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

18. COST ANALYSIS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER TOTAL KNEE REPLACEMENT AND TOTAL HIP REPLACEMENT

Marmarali B., Altintas F., Bal K., Bozkurt K., Demir M., Erdemli B., et al.

VALUE IN HEALTH , cilt.15, sa.4, 2012 (SCI-Expanded)

19. The functional SLC11A1 gene polymorphisms are associated with sarcoidosis in Turkish population.

AKÇAKAYA P., AZEROGLU B., EVEN I., ATES O., TURKER H., Ongen G., et al.

Molecular biology reports , cilt.39, ss.5009-16, 2012 (SCI-Expanded)

20. Venous Thromboembolism Risk and Thromboprophylaxis Among Hospitalized Patients: Data From the Turkish Arm of the ENDORSE Study

Ongen G., YILMAZ A., CIRAK A. K., ERSOY C. Y., Erden F., ALTINTAS F., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.17, sa.5, ss.539-545, 2011 (SCI-Expanded)

21. Extrapulmonary involvement in patients with sarcoidosis in Turkey

Okumus G., Musellim B., Cetinkaya E., Turker H., Uzaslan E., Yenturk E., et al.

RESPIROLOGY , cilt.16, sa.3, ss.446-450, 2011 (SCI-Expanded)

22. 3p abnormalities in peripheral lymphocytes in small cell lung cancer

Tarkan-Arguden Y., Hacihanefioglu S., Ongen G., Erk M., Cenani A.

TUMORI , cilt.95, sa.4, ss.535-537, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

23. TNF GENE POLYMORPHISMS IN SARCOIDOSIS

Pamukcu C., Yalcin B., Ates O., Topal-Sarikaya A., TURKER H., Ongen G.

IUBMB LIFE , cilt.61, sa.3, ss.332-333, 2009 (SCI-Expanded)

24. NRAMP1 (SLC11A1): POSSIBLE CANDIDATE GENE FOR SARCOIDOSIS IN TURKISH POPULATION

Akcakaya P., Azeroglu B., Even I., Ates O., TURKER H., Ongen G., et al.

IUBMB LIFE , cilt.61, sa.3, ss.369-370, 2009 (SCI-Expanded)

25. Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement

Ates O., Musellim B., Ongen G., Topal-Sarikaya A.

RHEUMATOLOGY INTERNATIONAL , cilt.28, sa.11, ss.1123-1126, 2008 (SCI-Expanded)

26. Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis

Ates O., Musellim B., Ongen G., Topal-Sarikaya A.

JOURNAL OF CLINICAL IMMUNOLOGY , cilt.28, sa.3, ss.232-236, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

27. NRAMP1 (SLC11A1): A plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement

Ates O., Musellim B., Ongen G., Topal-Sarikaya A.

JOURNAL OF CLINICAL IMMUNOLOGY , cilt.28, sa.1, ss.73-77, 2008 (SCI-Expanded)

28. The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement

Musellim B., Ikitimur H., Uzun H., Ongen G.

RHEUMATOLOGY INTERNATIONAL , cilt.27, sa.2, ss.163-167, 2006 (SCI-Expanded)

29. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation

Musellim B., Erturan S., Duman E., Ongen G.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE , cilt.9, sa.11, ss.1220-1223, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Cytogenetic analysis of 11 squamous cell lung carcinomas

Tarkan-Arguden Y., Hacyhanefioolu S., Ongen G., Erk M., Cenani A.

CYTOGENETICS AND CELL GENETICS , cilt.81, sa.2, ss.157, 1998 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 12

1. COMPARISON OF DIFFERENT PULMONARY HYPERTENSION SCREENING ALGORITHMS IN PATIENTS WITH SYSTEMIC SCLEROSIS

Erdogan M., Avci B. K., Ebren C., Ersoy Y., Ongen Z., Ongen G., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.698-699, (Özet Bildiri)

2. PERFORMANCE OF DIFFERENT PULMONARY HYPERTENSION SCREENING ALGORITHMS IN PATIENTS WITH SYSTEMIC SCLEROSIS PATIENTS

Erdogan M., Avci B. K., Ersoy Y., Ebren C., Ongen Z., Ongen G., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.842, (Özet Bildiri)

3. Pulmoner arteryel hipertansiyonda serum lektin benzeri okside lipoprotein reseptöru¨-1’in endotel hasar belirteci olarak önemi ve hemodinamik parametreler ile olan iliskisi (SB-116)

UZUN H., YAŞAR İ., İKİTİMUR B., KILIÇKIRAN AVCI B., Güntaş Korkmaz G., ATAHAN E., et al.

30. Uluslararası Katılımlı Tu¨rk Kardiyoloji Kongresi, Antalya, Türkiye, 23 - 26 Ekim 2014, cilt.14, ss.36, (Özet Bildiri)

4. Predictors of long term survival in patients with pulmonary arterial hypertension

YURTSEVEN E., KILIÇKIRAN AVCI B., İKİTİMUR B., KARADAĞ B., ÖZCAN S., ATAHAN E., et al.

30. Uluslararası Katılımlı Tu¨rk Kardiyoloji Kongresi, Antalya, Türkiye, 23 - 26 Ekim 2014, cilt.14, ss.37

5. Pulmoner Arteryel Hipertansiyonda Vitamin D ve Paratiroid Hormon Du¨zeyleri

Güntaş G., UZUN H., YAŞAR İ., Irmak H., İKİTİMUR B., ATAHAN E., et al.

Tu¨rkiye Solunum Arastırmaları Dernegi 35. Ulusal Kongresi, Solunum 2013, İzmir, Türkiye, 2 - 06 Ekim 2013, ss.17

6. Pulmoner arteryel hipertansiyonda oksidatif stres parametreleri ile hemodinamik parametreler arasındaki iliski (SS-017)

UZUN H., KILIÇKIRAN AVCI B., YAŞAR İ., Güntaş Korkmaz G., İKİTİMUR B., ATAHAN E., et al.

Tu¨rkiye Solunum Arastırmaları Dernegi 35. Ulusal Kongresi, Solunum 2013, İzmir, Türkiye, 2 - 06 Ekim 2013, ss.20

12. The correlation between the clinical signs of pulmonary embolism and the lung scanning with high and intermediate probability

Ongen G., Musellim B., Erk M., Umut S., Kucukusta A., Onsel C.

1st Mediterranean Congress on Interventional Diagnosis for Thorax Diseases, RHODES, Yunanistan, 25 - 29 Mayıs 1996, ss.657-660, (Tam Metin Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

182

H-İndeks (WoS)

Atıf (Scopus)

209

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim